Insulin Potentiated Therapy (IPT) (IPT-LD) and Cancer

What is IPT ?

IPT is a therapeutic regime designed to increase the efficacy of conventional chemo- therapy while decreasing its toxicity to healthy cells. IPT involves the use of intravenous insulin in combination with chemotherapy to deliver medications into cancer cells in greater amounts than would ordinarily be normally expected. The goal is to decrease side effects and damage to normal healthy cells.

Generally FDA approved chemotherapeutic drugs are used. However, natural substance may also be administered.

Intravenously administered insulin lowers normal blood sugar in the body. While the blood sugar concentration is low, chemotherapeutic drugs are administered and enter cancer cells to a much greater extent than do normal cells. With greater amounts of chemotherapeutic drugs entering cancer cells and lesser amounts entering normal cells, bodily toxicity and resultant side effects are reduced.

When IPT is used to administer chemotherapy, routinely only 10-20% of the customary amount of chemotherapeutic agents is typically used to achieve the same cancer cell killing effects. The result is only 10-20% of the toxic exposure to the rest of the body resulting in a significant reduction of the otherwise usually observed side effects.

The treatment routinely involves the patient comfortably reclining in a chair in the outpatient setting receiving an infusion of water and minerals administered intravenously. Insulin is added to the intravenous infusion resulting in a temporary lowering of blood sugar which is monitored every few minutes until the desired blood sugar level is reached. Approximately one half hour after the injection of insulin while the sugar concentration is at its lowest, small amounts of chemotherapeutic medicines are administered intravenously. The blood sugar levels are then brought into balance with the infusion of intravenous dextrose, sweetened beverages, and eating healthy foods. The treatment typically takes just over one hour.

IPT is also referred to as IPT-LD, the letters LD meaning low dose. The objective is to achieve the same anticancer effects with less medication, fewer side effects, reduced organ damage, and less compromise of the immune system. A strong immune function is needed to fight cancer.